Gabather AB (publ) (FRA:5J2)

Market Cap	1.31M +15.3%
Revenue (ttm)	n/a
Net Income	-429.64K
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.0002
Previous Close	0.0002
Day's Range	0.0002 - 0.0002
52-Week Range	0.0002 - 0.0150
Beta	n/a
RSI	48.15
Earnings Date	Feb 6, 2026

About Gabather AB

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer’s disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer’s disease, schizophrenia, and major depressive disorders. The company was incorporated in 2014 and is based in Södertälje, Sweden.

• Industry: Pharmaceutical Preparations
• Founded: 2014
• Employees: 3
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5J2

Financial Performance

Financial numbers in SEK